Comparison between Niva Bupa Health Insurance IPO and Suraksha Diagnostic IPO.
Niva Bupa Health Insurance IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Suraksha Diagnostic IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Niva Bupa Health Insurance IPO is up to ₹2,200.00 Cr whereas the issue size of the Suraksha Diagnostic IPO is up to ₹846.25 Cr. The final issue price of Niva Bupa Health Insurance IPO is ₹74.00 per share and of Suraksha Diagnostic IPO is ₹441.00 per share.
| Niva Bupa Health Insurance IPO | Suraksha Diagnostic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹70.00 per share | ₹420.00 per share |
| Issue Price (Upper) | ₹74.00 per share | ₹441.00 per share |
| Issue Price (Final) | ₹74.00 per share | ₹441.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 200 shares | 34 shares |
| Fresh Issue Size | 10,81,08,108 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹800.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 18,91,89,188 shares | 1,91,89,330 shares |
| OFS Issue Size (Amount) | up to ₹1,400.00 Cr | up to ₹846.25 Cr |
| Issue Size Total | 29,72,97,296 shares | 1,91,89,330 shares |
| Issue Size Total (Amount) | up to ₹2,200.00 Cr | up to ₹846.25 Cr |
Niva Bupa Health Insurance IPO opens on Nov 07, 2024, while Suraksha Diagnostic IPO opens on Nov 29, 2024. The closing date of Niva Bupa Health Insurance IPO and Suraksha Diagnostic IPO is Nov 11, 2024, and Dec 03, 2024, respectively.
| Niva Bupa Health Insurance IPO | Suraksha Diagnostic IPO | |
|---|---|---|
| Anchor Bid Date | Nov 06, 2024 | Nov 28, 2024 |
| Issue Open | Nov 07, 2024 | Nov 29, 2024 |
| Issue Close | Nov 11, 2024 | Dec 03, 2024 |
| Basis Of Allotment (Tentative) | Nov 12, 2024 | Dec 04, 2024 |
| Initiation of Refunds (Tentative) | Nov 13, 2024 | Dec 05, 2024 |
| Credit of Share (Tentative) | Nov 13, 2024 | Dec 05, 2024 |
| Listing date (Tentative) | Nov 14, 2024 | Dec 06, 2024 |
| Anchor Lockin End date 1 | Dec 12, 2024 | Jan 03, 2025 |
| Anchor Lockin End date 2 | Feb 10, 2025 | Mar 04, 2025 |
Niva Bupa Health Insurance IPO P/E ratio is 153.7, as compared to Suraksha Diagnostic IPO P/E ratio of 99.31.
| Niva Bupa Health Insurance IPO | Suraksha Diagnostic IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 88.98 | 61.07 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 73.37 | 48.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 153.7 | 99.31 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹13380.91 Cr. | ₹2296.76 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 14.09% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 21.46% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.12 | 0.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹0.48 | ₹4.44 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -0.92 | 14.09% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Niva Bupa Health Insurance IPO Retail Individual Investors (RII) are offered 2,97,29,729 shares while in Suraksha Diagnostic IPO retail investors are offered 2,97,29,729 shares. Qualified Institutional Buyers (QIB) are offered 8,91,89,190 shares in Niva Bupa Health Insurance IPO and 38,37,867 shares in Suraksha Diagnostic IPO.
| Niva Bupa Health Insurance IPO | Suraksha Diagnostic IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,37,83,783 shares | 57,56,797 shares |
| Market Maker Reservation | ||
| QIB | 8,91,89,190 shares | 38,37,867 shares |
| NII | 4,45,94,594 shares | 28,78,400 shares |
| RII | 2,97,29,729 shares | 67,16,266 shares |
| Employee | ||
| Others | ||
| Total | 29,72,97,296 shares | 1,91,89,330 shares |
Niva Bupa Health Insurance IPO subscribed 1.90x in total, whereas Suraksha Diagnostic IPO subscribed 1.27x.
| Niva Bupa Health Insurance IPO | Suraksha Diagnostic IPO | |
|---|---|---|
| QIB (times) | 2.17x | 1.74x |
| NII (times) | 0.71x | 1.40x |
| Big NII (times) | 0.70x | 1.53x |
| Small NII (times) | 0.74x | 1.16x |
| RII (times) | 2.88x | 0.94x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.90x | 1.27x |
